Rapid Micro Biosystems
Owen Griffin is a biotechnology professional with extensive experience in microbiology and quality control within pharmaceutical and medical device industries. Currently serving as the Director of R&D Microbiology at Rapid Micro Biosystems since May 2022, Owen manages a team focused on new product development and automated microbial quality control solutions. Prior roles include Manager of Microbiology and Chemistry at Stryker, where Owen oversaw quality control testing for various products and served as interim stability program manager. Owen's career also includes significant positions at Evonik, where responsibilities involved managing microbiology laboratory operations for sterile pharmaceuticals, and roles at Southern Research Institute and Auburn University School of Veterinary Medicine, emphasizing drug discovery and laboratory techniques. Owen holds a Bachelor's degree in Microbiology and Laboratory Technology from Auburn University.
Rapid Micro Biosystems
1 followers
Rapid Micro Biosystems accelerates the detection of microbial contamination in the manufacture of pharmaceuticals, biologics, medical devices, and personal care products. The company’s Growth Direct™ Platform—the first and only growth-based platform to fully automate traditional microbial testing—detects contamination more quickly, delivering compelling economic benefits while improving quality control processes.